BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
IGF1
,
Angiogenesis
,
Pseudomonas infection
,
Embryo
,
Laser capture microdissection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
pyrrolidones
Summary
General Info
Curated Studies
Most Correlated Studies
Cutaneous melanoma after treatment with tumor necrosis factor (TNF) and melphalan
Explore Curated Studies Results
Literature
Most Relevant Literature
A Catalyst and Solvent Free Route for the Synthesis of N-Substituted Pyrrolidones from Levulinic Aci…
Batch and flow green microwave-assisted catalytic conversion of levulinic acid to pyrrolidones.
Regioselective Radical-Relay Sulfonylation/Cyclization Protocol to Sulfonylated Pyrrolidones under T…
Synthetic access to syn-functionalised chiral hydroxy pyrrolidines and pyrrolidones: Evaluation of α…
Manganese(III)-mediated radical cyclisations for the (Z)-selective synthesis of exo-alkylidene pyrro…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Neoadjuvant Inituomab, Pyrrolidone and Nab-paclitaxel for HER2+Breast Cancer
Collagen-PVP vs Hylan G-F 20 in the Treatment of Knee Osteoarthritis
A Phase 1 Study to Assess Pharmacokinetics of Metadoxine (MG01CI) 1400 mg, Administered to Healthy V…
A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive The…
NMP in Relapsed / Refractory Myeloma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ